Kailera Therapeutics Appoints Scott M. Akamine as Chief Legal Officer
November 12, 2024 08:00 ET
|
Kailera Therapeutics, Inc.
Today, Kailera Therapeutics announced the appointment of Scott Akamine as Chief Legal Officer.
Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions
October 01, 2024 07:00 ET
|
Kailera Therapeutics, Inc.
Kailera today announced its launch as a clinical-stage biopharmaceutical company advancing next-generation therapies for obesity and related conditions.